Search
for
Sort by
Research 691–720 of 1000+
- HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond
- Liposomes in cancer therapy
- Profile analysis of adverse events after boron neutron capture therapy for head and neck cancer: a sub-analysis of the JHN002 study
- Characteristics of non‐melanoma skin cancers of the cutaneous perioral and vermilion lip treated by Mohs micrographic surgery
- Erlotinib-Associated Alopecia in a Lung Cancer Patient
- Alopecia Neoplastica: A Manifestation of Metastatic Breast Cancer
- Analysis of the function of ADAM17 in iRhom2 curly-bare and tylosis with esophageal cancer mutant mice
- Low-Dose Dimethyl Sulfoxide (DMSO) Suppresses Androgen Receptor (AR) and Its Splice Variant AR-V7 in Castration-Resistant Prostate Cancer (CRPC) Cells
- In Vitro Evaluate the Antiproliferative Impact of Cnicus Benedictus L. Leaves Methanolic Extract on Cervical Cancer
- NEURONAL MIMICRY AS A RESISTANCE PHENOTYPE IN CANCER CELLS
- Urological Oncology: Prostate Cancer
- Slow progress in prostate cancer
- Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer
- Hair disorders in patients with cancer
- Three-Dimensional-Bioprinted Non-Small Cell Lung Cancer Models in a Mouse Phantom for Radiotherapy Research
- Safety of Whole-Body Abrogation of the TRF1 Shelterin Protein in Wild-Type and Cancer-Prone Mouse Models
- Long-term opioid ADR management in cancer patients
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- New Methods of Endocrine Management of Prostatic Cancer
- Anti-androgen hormonal therapy for cancer and other diseases
- The management of EGFR inhibitor adverse events: a case series and treatment paradigm
- A comparative analysis of immune privilege in pregnancy and cancer in the context of checkpoint blockade immunotherapy
- Common urologic diseases in older men and their treatment: how they impact fertility
- Unraveling the Role of Repurposed Drugs in the Treatment of Acne: Success so Far and the Road Ahead
- Decade Long Survey of Low-level Laser Therapy/Photobiomodulation (LLLT/PBM) Therapy for Oral Mucositis Treatment
- Role of the SOX family in cancer immune evasion: Emerging player and promising therapeutic opportunities
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- ORAL AND TOPICAL FINASTERIDE IN THE TREATMENT OF MALE ANDROGENETIC ALOPECIA – NARRATIVE REVIEW